Response to Takahashi

Affiliations

¹ Department of Urology, Weill Cornell Medicine/New York-Presbyterian, New York, NY, USA.
² Department of Healthcare Policy and Research, Weill Cornell Medicine, New York, NY, USA.
³ Department of Urology, Northwestern University, Chicago, IL, USA.
⁴ Department of Radiation Oncology, Weill Cornell Medicine/New York-Presbyterian, New York, NY, USA.
⁵ Department of Surgery (Urology Service), Memorial Sloan Kettering Cancer Center, New York, NY, USA.
⁶ Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
⁷ Department of Urology, Institute of Clinical Sciences, Department of Urology, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden.

Comment

Leonardo D Borregales et al. J Natl Cancer Inst. 2022.

. 2022 Nov 14;114(11):1557-1558.

doi: 10.1093/jnci/djac146.

¹ Department of Urology, Weill Cornell Medicine/New York-Presbyterian, New York, NY, USA.
² Department of Healthcare Policy and Research, Weill Cornell Medicine, New York, NY, USA.
³ Department of Urology, Northwestern University, Chicago, IL, USA.
⁴ Department of Radiation Oncology, Weill Cornell Medicine/New York-Presbyterian, New York, NY, USA.
⁵ Department of Surgery (Urology Service), Memorial Sloan Kettering Cancer Center, New York, NY, USA.
⁶ Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
⁷ Department of Urology, Institute of Clinical Sciences, Department of Urology, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden.

No abstract available

Comment on

RE: Grade Migration of Prostate Cancer in the United States During the Last Decade.
Takahashi T. Takahashi T. J Natl Cancer Inst. 2022 Nov 14;114(11):1553-1554. doi: 10.1093/jnci/djac145. J Natl Cancer Inst. 2022. PMID: 35880870 Free PMC article. No abstract available.

1. Epstein JI, Zelefsky MJ, Sjoberg DD, et al.A contemporary prostate cancer grading system: a validated alternative to the Gleason score. Eur Urol. 2016;69(3):428-435. - PMC - PubMed
1. Patel NA, Sedrakyan A, Bianco F, et al.Definitive and sustained increase in prostate cancer metastases in the United States. Urol Oncol. 2019;37(12):988-990. - PMC - PubMed
1. Jemal A, Culp MB, Ma J, Islami F, Fedewa SA.. Prostate cancer incidence 5 years after US Preventive Services Task Force recommendations against screening. J Natl Cancer Inst. 2021;113(1):64-71. - PMC - PubMed
1. Desai MM, Cacciamani GE, Gill K, et al.Trends in incidence of metastatic prostate cancer in the US. JAMA Netw Open. 2022;5(3):e222246. - PMC - PubMed
1. Burgess L, Aldrighetti CM, Ghosh A, et al.Association of the USPSTF grade D recommendation against prostate-specific antigen screening with prostate cancer–specific mortality. JAMA Netw Open. 2022;5(5):e2211869. - PMC - PubMed